In Silico Trial Design in Development of Rare Disease Cell and Gene Therapies

Speakers:

Abie Ekangaki, Ph.D.
Vice President, Statistical Consulting

Kenneth Ndugga-Kabuye, MD, FACMG
Vice President, Cell & Gene Therapy

Consulting

3 Characteristics of a Successful Cell and Gene Therapy Nonclinical Program

By Madelyn Huang

April 24, 2024

Consulting

Design Considerations in Nonclinical Development of Cell and Gene Therapies

By Premier Research

April 23, 2024

Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients

Listen Now